About Acadia Pharmaceuticals
We take on challenges in neuroscience and rare disease to deliver solutions to people who need them most.
We are Acadia
From paediatric to geriatric, we work together to advance understanding and care across neurology, psychiatry, long-term care, rare disease, and mental health. We’re bringing new understanding to these disease areas. For our families, friends and neighbours. For the millions of people affected by neurological and rare disorders who are fighting for their future every day.
Leading Innovative Treatments
We developed and commercialised a treatment option for patients with hallucinations and delusions associated with Parkinson's disease psychosis in the United States, as well as another treatment option for patients with Rett syndrome in the United States and Canada. We are working to seek approval of our treatment option for people living with Rett syndrome in Europe.
Developing Therapies for Unmet Needs
Our clinical-stage development efforts are focused on Prader-Willi syndrome, Alzheimer’s disease psychosis, essential tremor, and multiple other programmes targeting neuropsychiatric symptoms in central nervous system disorders.
Join Our Team
We are seeking individuals with diverse skills, experiences, and backgrounds to join our growing team. Headquartered in San Diego, California, with a presence across Europe, the United States, and Canada, we are building a world-class organisation dedicated to working to improve the standard of care in neuroscience and rare disease.
